欧洲鼻窦炎鼻息肉立场文件2020(EPOS2020)
EPOS2020是2005、2007和2012年同名循证立场文件的更新,核心目标是为急性和慢性鼻窦炎提供修订的、最新的循证推荐和整合诊疗路径。文件系统综述了成人及儿童急慢性鼻窦炎(伴或不伴鼻息肉)的管理证据,纳入药师和患者等新利益相关方,并提出将慢性鼻窦炎分为原发性和继发性、按解剖分布分为局限性和弥漫性的新分类。
要点
- 提出慢性鼻窦炎新分类:原发性与继发性,再按解剖分布分为局限性和弥漫性。
- 系统综述成人及儿童急慢性鼻窦炎(伴或不伴鼻息肉)的全部可用证据并给出整合诊疗路径。
- 涉及儿科急慢性鼻窦炎和鼻窦手术等EPOS2012未充分覆盖的领域,并纳入药师和患者视角。
核心结论
- EPOS2020为急性和慢性鼻窦炎提供修订的、最新的循证推荐和整合诊疗路径。
- 提出慢性鼻窦炎新分类:原发性和继发性,并按解剖分布分为局限性和弥漫性疾病。
- 尽管近年高质量发表物显著增加,大量实际临床问题仍存,通过Delphi流程整合结果。
研究设计与样本
- 本文件为2005、2007和2012年同名循证立场文件的更新版。
- 系统综述自EPOS2012发表后八年内发表的文献和开展的研究。
- 纳入药师和患者等新利益相关方,并面向药师、护士、专业照护者和患者等新目标用户。
主要发现
- 文件包含定义和分类章节,定义了大量术语并标明首选术语。
- 文件包含流行病学和易感因素、炎症机制、面痛鉴别诊断、变应性鼻炎、遗传学、囊性纤维化、阿司匹林加重性呼吸疾病、免疫缺陷、变应性真菌性鼻窦炎及上下气道关系的广泛章节。
- 儿科急性和慢性鼻窦炎章节完全重写。
- 文件包含患者和药师建议以及新的研究需求清单。
关键数值与推荐
- 提出慢性鼻窦炎新分类:原发性和继发性,并按解剖分布进一步分为局限性和弥漫性疾病。
临床怎么用
- 临床可依据EPOS2020的循证推荐和整合诊疗路径管理成人及儿童急慢性鼻窦炎。
- 可采用新的慢性鼻窦炎分类框架(原发性/继发性、局限性/弥漫性)进行疾病分型。
- 药师、护士、专业照护者和患者可参考文件中针对其角色的建议参与鼻窦炎管理。
局限性
- 尽管近年高质量发表物显著增加,大量实际临床问题仍存。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The European Position Paper on Rhinosinusitis and Nasal Polyps 2020 is the update of similar evidence based position papers published in 2005 and 2007 and 2012. The core objective of the EPOS2020 guideline is to provide revised, up-to-date and clear evidence-based recommendations and integrated care pathways in ARS and CRS. EPOS2020 provides an update on the literature published and studies undertaken in the eight years since the EPOS2012 position paper was published and addresses areas not extensively covered in EPOS2012 such as paediatric CRS and sinus surgery. EPOS2020 also involves new stakeholders, including pharmacists and patients, and addresses new target users who have become more involved in the management and treatment of rhinosinusitis since the publication of the last EPOS document, including pharmacists, nurses, specialised care givers and indeed patients themselves, who employ increasing self-management of their condition using over the counter treatments. The document provides suggestions for future research in this area and offers updated guidance for definitions and outcome measurements in research in different settings. EPOS2020 contains chapters on definitions and classification where we have defined a large number of terms and indicated preferred terms. A new classification of CRS into primary and secondary CRS and further division into localized and diffuse disease, based on anatomic distribution is proposed. There are extensive chapters on epidemiology and predisposing factors, inflammatory mechanisms, (differential) diagnosis of facial pain, allergic rhinitis, genetics, cystic fibrosis, aspirin exacerbated respiratory disease, immunodeficiencies, allergic fungal rhinosinusitis and the relationship between upper and lower airways. The chapters on paediatric acute and chronic rhinosinusitis are totally rewritten. All available evidence for the management of acute rhinosinusitis and chronic rhinosinusitis with or without nasal polyps in adults and children is systematically reviewed and integrated care pathways based on the evidence are proposed. Despite considerable increases in the amount of quality publications in recent years, a large number of practical clinical questions remain. It was agreed that the best way to address these was to conduct a Delphi exercise . The results have been integrated into the respective sections. Last but not least, advice for patients and pharmacists and a new list of research needs are included. The full document can be downloaded for free on the website of this journal: http://www.rhinologyjournal.com.
引用
- Fokkens WJ, Lund VJ, Hopkins C, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020. PMID: 32077450. doi:10.4193/Rhin20.600
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。